The NHS Quality Strategy 2026: What Does It Mean for Patient Safety and PSIRF?
On 14 July 2026, NHS England published the new Quality Strategy for NHS-funded care in England on behalf of the National Quality Board. It describes a 10-year approach intended to make quality the organising principle for NHS-funded care. The strategy applies across the system, not only to NHS trusts, and places safety, effectiveness and experience at the centre of how quality should be understood, managed and improved.
At first glance, some of this will feel familiar. Safety, effectiveness and patient experience are not new concepts. Neither are calls for better leadership, clearer accountability, stronger patient voice or improved use of data.
Is this genuinely a new direction, or is it a clearer attempt to make the NHS deliver what previous quality strategies and frameworks already promised? |
I think the answer is a bit of both.
The strategy does not claim to introduce a new collection of requirements. Instead, it brings together existing commitments and places greater emphasis on consistency, transparency, outcomes, equity and value. NHS organisations are expected to use it to inform local priorities, improvement programmes and performance oversight, while considering safety, effectiveness and experience together.
That matters for patient safety, and it matters particularly for organisations reviewing how successfully they have implemented the Patient Safety Incident Response Framework, or PSIRF.
What does the new Quality Strategy set out to achieve?
The strategy aims to produce sustained, measurable improvement over the next decade. Its intended outcomes include:
· improved health outcomes and healthy life expectancy
· reduced healthcare inequalities
· improved patient satisfaction
· more consistent evidence-based care
· clearer accountability for quality
· greater transparency about outcomes and variation
· improved value from the resources available to the NHS.
Importantly, quality is not presented as a specialist function owned by a quality team. The strategy says responsibility exists at every level, including national bodies, commissioners, boards, clinical leaders, frontline teams and individual professionals. Organisational accountability must, however, remain visible and clear.
This is an important distinction.
When responsibility belongs to everyone, there is always a risk that accountability belongs to nobody. The strategy appears to recognise this and places significant weight on clear leadership, effective quality management and public accountability for outcomes.
It identifies 10 enablers:
1. clarifying responsibility and accountability
2. setting clear priorities
3. strengthening leadership and management capability
4. listening to and working with people and communities
5. using data to manage quality
6. increasing transparency
7. embedding technology in quality management
8. aligning incentives with high-quality and productive care
9. promoting innovation and research
10. creating more co-ordinated, improvement-focused regulation.
These enablers give the strategy more operational substance than a simple statement of ambition. However, their value will depend on whether they influence the real management of services, rather than becoming another reporting framework sitting alongside existing governance processes.
What has changed from previous approaches to quality?
It is worth being careful with the comparison. The NHS has had several national quality frameworks and commitments, rather than one continuous series of documents all bearing the title “quality strategy”.
Lord Darzi’s 2008 report, High Quality Care for All, established the enduring definition of quality through patient safety, clinical effectiveness and patient experience. It also promoted better information, clinical leadership, local improvement and a move away from relying solely on centrally imposed activity targets.
The National Quality Board’s 2016 Shared Commitment to Quality subsequently promoted a nationally agreed definition, consistent standards, a common language, coherent assurance and a culture in which staff could speak up. Its 2021 refresh responded to the emergence of integrated care systems, placing greater emphasis on partnership working, population health, health inequalities and quality across organisational boundaries.
The new strategy retains much of that foundation, but there are several changes in emphasis.
1. From defining quality to managing it
Previous documents did important work in establishing a shared understanding of quality. The 2026 strategy goes further in describing how the NHS should manage, measure and account for it.
There is a stronger focus on quality management systems, operational capability, data, accountability and governance. The strategy is therefore not only asking organisations whether they share the right ambition. It is asking whether their local systems can reliably turn that ambition into consistently safe, effective and person-centred care.
2. From organisational quality to pathway and system quality
The strategy acknowledges that attention has historically concentrated on hospitals, secondary care and individual organisations. It calls for a broader view that includes primary care, community services, mental health services and entire patient pathways. Modern service frameworks will be used to address variation and improve outcomes across priority conditions and population groups.
Patients experience pathways, but organisations often govern services. |
Risk can sit in the gaps between teams, systems and providers. If quality assurance stops at the organisational boundary, it may provide a reassuring view of each component while missing how the overall pathway actually performs.
3. A much stronger emphasis on value
The strategy explicitly connects quality with value, productivity and the effective use of resources. It calls for resources to be directed towards interventions that deliver the greatest health benefit, reduce inequality and improve outcomes. This is partly a response to the Dash Review’s concerns about fragmented accountability, duplication and insufficient attention to effective resource use.
Value should not be understood simply as cost reduction.
Poorly designed care creates waste. So do repeated investigations that produce little learning, safety actions that cannot be implemented, duplicated assurance mechanisms and governance reports that describe activity without demonstrating improvement.
Getting quality right by design should make care safer and resources more effective.
4. Greater transparency and public accountability
The strategy aims to make quality data more open, accessible and meaningful. The National Quality Board is expected to oversee a core set of measures across safety, effectiveness and experience, supported by data on trends, geographical variation and inequalities.
This is potentially valuable, but transparency must produce insight rather than simply more data.
A dashboard can show that something has changed. It cannot always tell us why. It may also fail to reveal weak signals, workarounds, under-reporting or the experiences of people whose voices are least visible in formal datasets.
5. Quality is more explicitly connected to inequalities
The 2021 Shared Commitment already strengthened the focus on population health and health inequalities. The new strategy moves this further into the measurement and prioritisation of quality, including variation in access, experience, safety and outcomes.
This means organisations should not assume that an apparently acceptable average represents equitable care. A system may perform well overall while particular communities or groups experience substantially higher risk, poorer access or worse outcomes.
Does the Quality Strategy change the NHS Patient Safety Strategy?
Not immediately.
The 2026 Quality Strategy does not replace the NHS Patient Safety Strategy. It describes safety as the foundation of quality and provides the wider framework within which patient safety activity should operate. NHS England has also confirmed that an updated Patient Safety Strategy will be developed, following work to align patient safety management with the Quality Strategy and reduce duplication.
The likely effect is therefore one of alignment and integration, rather than immediate replacement.
The original Patient Safety Strategy was built around two foundations, patient safety culture and patient safety systems, and three strategic aims: insight, involvement and improvement. Those principles remain highly compatible with the new Quality Strategy’s emphasis on leadership, community voice, data, transparency, improvement and accountable quality management.
There may, however, be a shift in how patient safety is positioned.
Patient safety must remain visible as a distinct discipline, but it should not operate as a disconnected vertical programme. NHS England’s April 2026 position statement on safety management systems makes this point directly: patient safety should be integrated into the organisation’s wider management system while retaining explicit priority and visibility.
That balance will be important. Integrating safety into quality must not dilute it. Equally, protecting safety must not mean isolating it from experience, effectiveness, workforce, digital transformation, finance or operational decision-making.
Does the latest Patient Safety Strategy progress update align with the Quality Strategy?
Broadly, yes.
The July 2026 progress update reports that the Patient Safety Strategy is now achieving the impact anticipated at its launch, described as saving 1,000 additional lives and £100 million annually. It highlights improvements involving deterioration, maternity and neonatal care, medicines safety, incident response, workforce capability, patient involvement, primary care and digital clinical safety.
There is strong alignment in several areas.
Outcomes and value
The progress update connects safety work with measurable outcomes. It reports, for example, neonatal lives saved, reductions in cerebral palsy associated with magnesium sulphate use, fewer opioid-related harms and reductions in harmful exposure to valproate. It also identifies financial benefits arising from avoided harm and reduced demand.
This fits the Quality Strategy’s focus on outcomes, evidence, value and scalable improvement.
Patient and family voice
Martha’s Rule, the Patient Safety Partner role and the framework for involving patients in patient safety all support the Quality Strategy’s emphasis on listening to communities and strengthening the voice of patients, families and staff. Martha’s Rule alone supported earlier intervention for more than 1,000 people in its first year, including approximately 400 transfers to higher levels of care.
Data and transparency
The Learn from Patient Safety Events service is now used across NHS trusts and captures more than three million events each year. Planned work includes improving data quality and insight and publishing a recorded-data dashboard. This aligns closely with the Quality Strategy’s transparency and data ambitions.
However, recording more data does not automatically mean that organisations understand more.
The real test is whether data are triangulated with complaints, claims, mortality reviews, staff concerns, patient experience, audit, operational pressures, good catches and weak signals. Data must inform decisions and improvement, not just feed national collections.
Capability and culture
The progress update describes a network of more than 800 Patient Safety Specialists, extensive completion of the national patient safety syllabus and the continued development of Patient Safety Partners. This supports the Quality Strategy’s focus on leadership capability, workforce development, culture and meaningful involvement.
There is therefore considerable alignment between the two strategies. The gap is not primarily one of policy intent. It is the familiar gap between implementation and impact.
What does the Quality Strategy mean for PSIRF?
The most important point is that PSIRF should not be treated as a stand-alone investigation process.
The July 2026 progress update confirms that PSIRF has been implemented across NHS secondary care providers and is being piloted in more than 200 GP practices. NHS England describes it as a systems-focused approach centred on learning, improvement and better engagement with patients, families and staff.
The Quality Strategy reinforces several expectations that should now shape local PSIRF reviews.
PSIRF plans must connect to organisational quality priorities
A Patient Safety Incident Response Plan should not be based only on historical incident categories. It should draw on a broad analysis of organisational data and consider where learning responses can make the greatest contribution to safety improvement. Current PSIRF standards require a thorough analysis of relevant organisational data and alignment between patient safety, quality improvement and clinical governance systems.
The new strategy strengthens the case for connecting PSIRF priorities with:
· quality objectives
· pathway outcomes
· inequality data
· patient and staff experience
· strategic risks
· digital transformation
· operational pressures
· workforce risks
· complaints and claims
· mortality and medical examiner insight
· improvement capability and capacity.
Learning must lead to measurable improvement
Producing a good Patient Safety Incident Investigation report is not the end point.
The Quality Strategy’s emphasis on outcomes and value should encourage organisations to ask:
· Did the learning response identify the system conditions that shaped the event?
· Were patients, families and staff meaningfully involved?
· Were the resulting safety actions designed with the people expected to use them?
· Are the actions feasible in the real working environment?
· How will we know whether risk has reduced?
· Did learning travel across organisational or pathway boundaries?
· Are improvements sustained six or 12 months later?
PSIRF was designed to move organisations from process-driven investigation towards proportionate, systems-based learning and improvement. Promethean HD’s existing work similarly emphasises compassionate engagement, human factors, work-as-done and safety actions capable of producing meaningful change.
Oversight must provide insight, not simply assurance
A committee can receive every report on time and still know very little about whether the organisation is becoming safer.
Boards and quality committees will need to connect PSIRF evidence with the wider picture of safety, effectiveness and experience. This includes asking whether the organisation is hearing weak signals, understanding variation and identifying risks before they become serious harm.
The question should not only be: “Have we completed the required learning response?” It should be: “What has this taught us about the way our system really works, and what evidence do we have that care is now safer?” |
What should organisations do now?
I would suggest six practical actions.
1. Map the Quality Strategy against the current quality and patient safety governance framework. Identify duplication, gaps, unclear responsibilities and committees receiving information without the authority or capability to act.
2. Review the PSIRF plan against wider quality intelligence. Test whether local priorities reflect pathways, inequalities, patient experience, staff concerns and emerging risks, rather than incident volumes alone.
3. Strengthen the link between learning and improvement. Make sure learning response teams, quality improvement teams, operational leaders and those affected by incidents work together.
4. Review board and committee measures. Balance lagging harm measures with leading indicators, weak signals, implementation evidence and measures of sustained improvement.
5. Test patient safety capability and capacity. Having trained staff is important, but organisations must also provide the time, authority, support and psychological safety required to use those skills.
6. Look across organisational boundaries. Review how insight and accountability travel through pathways involving primary, community, acute, mental health, independent and social care partners.
How Promethean HD can support your organisation
Promethean HD supports NHS and independent healthcare organisations to turn national patient safety and quality expectations into practical, sustainable local systems.
Our support can include:
The focus is not on adding another layer of governance. It is on helping organisations understand whether their existing arrangements provide meaningful insight, support learning and improve care.
The new Quality Strategy creates an opportunity to bring quality, patient safety, human factors, governance and improvement together more effectively.
The risk is that organisations respond by creating more documentation, more dashboards and more meetings.
The opportunity is to do something different: to design quality into the way services are planned, delivered, governed and improved.
Getting it right by design, not luck. |
If your organisation is reviewing its PSIRF plan, patient safety arrangements, quality governance framework or board assurance processes, Promethean HD can provide independent, practical support tailored to your services and risks.
You can find out more about PSIRF here.
You can find out more about our
Comments